Smg8/smg9 heterodimer loss modulates smg1 kinase to drive atr inhibitor resistance

HIGHLIGHTS

• who: Anil Negi from the The Institute of Cancer Research, London, United Kingdom The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom. Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom. The healthcare business of Merck KGaA, Biopharma RandD, Translational Innovation Platform Oncology, Darmstadt, Germany. The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom. Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain. CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. have published the article: SMG8/SMG9 Heterodimer Loss Modulates . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.